Huntington’s

Showing 4 posts of 4 posts found.

Roche's building

Roche’s Huntington’s disease treatment disappoints in Phase III trial

March 23, 2021
Manufacturing and Production Huntington's, Phase III trial, Roche, huntington's disease, tominersen

Roche has discontinued dosing in a Phase III trial of its tominersen treatment for Huntington’s disease, following discouraging initial data.

c_gajus_-_fotolia

Teva and Intel team up to tackle Huntington’s with wearable tech

September 16, 2016
Medical Communications Huntington's, Intel, Teva, wearable tech

Israeli pharma firm Teva is joining forces with technology giant Intel to tackle the debilitating disease Huntington’s with cutting-edge wearable …

roche_close

Roche signs Huntington’s deal

April 10, 2013
Research and Development, Sales and Marketing Huntington's, Isis, Roche

Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …

Pharma pools trial data for brain disorder research

June 14, 2010
Research and Development Alzheimer's, Huntington's, Parkinson's, clinical trials, partnerships

Leading pharma companies have come together for a major new research collaboration aimed at improving clinical trials for Alzheimer’s, Parkinson’s, …

Latest content